Premium Information is available for this item - Upgrade for $1 a day
6505-01-051-6513
Usp Levothyroxine Sodium Tablets
6505010516513 010516513 3P1063 SYNTHROID
November 2023
10
Marketplace 6505-01-051-6513
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-051-6513 5+ Documents (More...)
Usp Levothyroxine Sodium Tablets 010516513 SYNTHROID https//www.nsnlookup.com /fsg-65/fsc-6505/
Usp Levothyroxine Sodium Tablets 010516513 SYNTHROID www.nsnlookup.com /fsg-65/fsc-6505/us 6505
Sodium Tablets6505010516513 010516513 3P1063 SYNTHROID Upgrade 6505-01-178-3941Usp Levothyroxine Sodium
Tablets6505011783941 011783941 NDC00048-1090-13 SYNTHROID 3P1083 SYNTHROID TABLETS Managed by United
04687 - Baxter Healthcare Corp (Active) Incomplete (Active) Primary Buy RNCC 3 RNVC 2 DAC 6 SYNTHROID
Usp Levothyroxine Sodium Tablets 010516513 your Account Upgrade 6505-01-051-6513Usp Levothyroxine
(Active) Primary Buy RNCC 3 RNVC 2 DAC 6 SYNTHROID 04687 - Baxter Healthcare Corp (Active) Incomplete
11 Aug 1977 Data Last Changed November 2023 (Active) Primary Buy RNCC 3 RNVC 2 DAC 6 SYNTHROID 04687
Usp Levothyroxine Sodium Tablets 010516513 SYNTHROID 04687 - Baxter Healthcare Corp (Active) Incomplete
(Active) Primary Buy RNCC 3 RNVC 2 DAC 6 SYNTHROID www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-051
Restrictions 6505-01-051-6513
6505-01-051-6513 is a Usp Levothyroxine Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-01-051-6513
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
- United States of America (ZZ)
Approved Sources 6505-01-051-6513
- Part Number
- Manufacturer
- Status
- 3P1063
- Manufacturer
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Reference
- Incomplete Reference
- SYNTHROID
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-051-6513
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 0.100 Milligrams Levothyroxine Sodium Active Ingredient
- Primary Container Type [CQCT]
- Strip
- Primary Container Content Quantity [CRLK]
- 10.000 Tablets
- Total Primary Container Quantity [CSCW]
- 10
NATO Stock Numbers Related to 6505-01-051-6513
Freight Information 6505-01-051-6513
6505-01-051-6513 has freight characteristics.. 6505-01-051-6513 has a variance between NMFC and UFC when transported by rail and the description should be consulted.